EGF/EGFR upregulates and cooperates with Netrin-4 to protect glioblastoma cells from DNA damage-induced senescence
Abstract Background Glioblastoma multiforme (GBM) is the most malignant central nervous system tumor. Alkylating agent, temozolomide (TMZ), is currently the first-line chemotherapeutic agent for GBM. However, the sensitivity of GBM cells to TMZ is affected by many factors. And, several clinic trials...
Main Authors: | Li Li, Yulun Huang, Yuge Gao, Tengfei Shi, Yunyun Xu, Huini Li, Marko Hyytiäinen, Jorma Keski-Oja, Qiuying Jiang, Yizhou Hu, Zhimin Du |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-018-5056-4 |
Similar Items
-
Senescent Cell-Secreted Netrin-1 Modulates Aging-Related Disorders by Recruiting Sympathetic Fibers
by: Ai Qing Yu, et al.
Published: (2020-12-01) -
NETRIN-4 protects glioblastoma cells FROM temozolomide induced senescence.
by: Li Li, et al.
Published: (2013-01-01) -
Targeting netrin‐3 in small cell lung cancer and neuroblastoma
by: Shan Jiang, et al.
Published: (2021-04-01) -
Relationship of serum netrin-1 levels with breast masses
by: İbrahim Solak, et al.
Published: (2018-10-01) -
Targeting Netrin-1 and -4 as a Novel Diagnostic Parameter and Treatment Option for Diabetic Retinopathy
by: Zewdie KA, et al.
Published: (2020-06-01)